BC Cancer Agency Joins Illumina Network; Ambry Offering MiSeq Services | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The British Columbia Cancer Agency Genome Science Center has joined the Illumina Genome Network, the San Diego-based firm said this week.

Research institutes that join the IGN have completed the firm's Certified Service Provider certification. Each of the partners in the network also have at least 10 Illumina sequencing systems.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.